Compare Dr. Reddys with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ABBOTT INDIA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ABBOTT INDIA DR. REDDYS LAB/
ABBOTT INDIA
 
P/E (TTM) x 21.5 47.6 45.3% View Chart
P/BV x 3.2 13.6 23.7% View Chart
Dividend Yield % 0.7 0.5 144.7%  

Financials

 DR. REDDYS LAB   ABBOTT INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
ABBOTT INDIA
Mar-18
DR. REDDYS LAB/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,8756,110 47.1%   
Low Rs1,8883,996 47.2%   
Sales per share (Unadj.) Rs930.21,552.2 59.9%  
Earnings per share (Unadj.) Rs117.4188.8 62.2%  
Cash flow per share (Unadj.) Rs185.8196.4 94.6%  
Dividends per share (Unadj.) Rs20.0055.00 36.4%  
Dividend yield (eoy) %0.81.1 77.2%  
Book value per share (Unadj.) Rs844.4796.6 106.0%  
Shares outstanding (eoy) m166.0721.25 781.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.63.3 78.6%   
Avg P/E ratio x20.326.8 75.8%  
P/CF ratio (eoy) x12.825.7 49.8%  
Price / Book Value ratio x2.86.3 44.5%  
Dividend payout %17.029.1 58.5%   
Avg Mkt Cap Rs m395,496107,376 368.3%   
No. of employees `00022.03.3 661.2%   
Total wages/salary Rs m33,5623,937 852.5%   
Avg. sales/employee Rs Th7,032.89,929.3 70.8%   
Avg. wages/employee Rs Th1,527.91,185.1 128.9%   
Avg. net profit/employee Rs Th887.71,207.7 73.5%   
INCOME DATA
Net Sales Rs m154,48232,985 468.3%  
Other income Rs m3,3751,170 288.5%   
Total revenues Rs m157,85734,155 462.2%   
Gross profit Rs m31,7825,245 605.9%  
Depreciation Rs m11,348162 7,009.3%   
Interest Rs m88938 2,327.2%   
Profit before tax Rs m22,9206,215 368.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,8582,203 175.1%   
Profit after tax Rs m19,5004,012 486.0%  
Gross profit margin %20.615.9 129.4%  
Effective tax rate %16.835.4 47.5%   
Net profit margin %12.612.2 103.8%  
BALANCE SHEET DATA
Current assets Rs m111,10122,655 490.4%   
Current liabilities Rs m58,9736,681 882.7%   
Net working cap to sales %33.748.4 69.7%  
Current ratio x1.93.4 55.6%  
Inventory Days Days7965 122.5%  
Debtors Days Days9429 323.1%  
Net fixed assets Rs m101,245835 12,118.3%   
Share capital Rs m830213 390.6%   
"Free" reserves Rs m139,40616,715 834.0%   
Net worth Rs m140,23616,928 828.4%   
Long term debt Rs m22,0000-   
Total assets Rs m224,65624,162 929.8%  
Interest coverage x26.8163.7 16.4%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.71.4 50.4%   
Return on assets %9.116.8 54.1%  
Return on equity %13.923.7 58.7%  
Return on capital %14.936.9 40.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,673369 24,060.6%   
Fx outflow Rs m19,1043,807 501.9%   
Net fx Rs m69,569-3,438 -2,023.5%   
CASH FLOW
From Operations Rs m28,7041,527 1,879.8%  
From Investments Rs m-7,727-2,148 359.7%  
From Financial Activity Rs m-21,326-1,024 2,082.0%  
Net Cashflow Rs m-314-1,646 19.1%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 7.9 68.4%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 17.1 89.5%  
Shareholders   75,885 18,270 415.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   PROCTER & GAMBLE HEALTH  IPCA LABS  JUBILANT LIFE SCIENCES  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 200 Points; Yes Bank and Reliance Industries Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. All sectoral indices are trading in green with stocks in the capital goods sector.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 18, 2019 02:35 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS